Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ágnes Bégány"'
Autor:
Szilvia Ecsedi, Margit Balázs, Zoltán Szentirmay, Márk Barok, Ágnes Bégány, Laura Vízkeleti, Zsuzsa Rákosy, Zsuzsa Krekk, Zoltán Vokó, Mónika Gallai, Róza Ádány
Publikováno v:
International Journal of Cancer. 121:1729-1737
Copy number alterations of the epidermal growth factor receptor (EGFR) gene have been extensively analyzed in different cancers, but no data are available for primary malignant melanoma. The aim of the present study was to simultaneously investigate
Autor:
László Kardos, Ágnes Bégány, Katalin Gilde, Margit Balázs, Róza Ádány, Zsuzsa Rákosy, Andrea Treszl
Publikováno v:
Cytometry Part B: Clinical Cytometry. :37-46
Background Amplification of c-myc is a common genetic alteration and associated with a poor prognosis in a variety of cancers. Extra copies of the gene have been found in large numbers of melanoma metastases, but only few primary tumours have been st
Publikováno v:
Acta Dermato-Venereologica. 84:116-119
Autoimmune blistering diseases (pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid, dermatitis herpetiformis) and certain genodermatoses with acantholysis (Darier-disease, Hailey-Hailey disease) have different aetiological factors, but all r
Publikováno v:
Cytometry. 46:222-232
Characteristic genetic changes underlying the metastatic progression of malignant melanoma is incompletely understood. The goal of our study was to explore specific chromosomal alterations associated with the aggressive behavior of this neoplasm. Com
Autor:
Gábor Boross, Viktória Lázár, Laura Vízkeleti, Balázs Szappanos, Róza Ádány, Ágnes Bégány, Margit Balázs, Zsuzsa Rákosy, Gabriella Emri, Szilvia Ecsedi
Somatic mutations of BRAF and NRAS oncogenes are thought to be among the first steps in melanoma initiation, but these mutations alone are insufficient to cause tumor progression. Our group studied the distinct genomic imbalances of primary melanomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcd724b25568f99f090e432cfa84d768
Autor:
Margit Balázs, Szilvia Ecsedi, Adrienn Orosz, Ágnes Bégány, Reka Toth, Gabriella Emri, Laura Vízkeleti, Róza Ádány, Gábor Méhes, Zsuzsa Rákosy, Attila G Szöllosi
Publikováno v:
Scopus-Elsevier
The 7q31 locus contains several genes affected in cancer progression. Although evidences exist regarding its impact on tumorigenesis, the role of genetic alterations and the expressions of locus-related genes are still controversial. Our study aimed
Publikováno v:
Breakthroughs in Melanoma Research
Malignant melanoma is considered the most aggressive form of skin cancer. The incidence rate of the disease has steadily risen over the past few decades throughout the world. If melanoma is diagnosed early, it can be cured by surgical resection, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb10790a6fed048f75bda04aef7daf19
http://www.intechopen.com/articles/show/title/genomics-of-human-malignant-melanoma
http://www.intechopen.com/articles/show/title/genomics-of-human-malignant-melanoma
Autor:
Ágnes Bégány, Róza Ádány, Reka Toth, Attila G Szöll odblac, Szilvia Ecsedi, Laura Vízkeleti, Margit Balázs, Zsuzsa Rákosy, Viktória Lázár
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 22(10)
Amplification of the 11q13 chromosomal region is a common event in primary melanomas. Several candidate genes are localized at this sequence; however, their role in melanoma has not been clearly defined. The aim of this study was to develop an accura
Autor:
Szilvia Ecsedi, Róza Ádány, Laura Vízkeleti, Ágnes Bégány, Zsuzsa Rákosy, Margit Balázs, Gabriella Emri
Publikováno v:
Cancer genetics and cytogenetics. 182(2)
Alteration of the CDKN2A (alias p16 ) tumor suppressor gene, located on 9p21, occurs frequently in familial and sporadic melanomas. Beside CDKN2A , other genes (e.g., CDKN2B , and ARF/p14 ARF , long considered distinct from CDKN2A ) on this locus are
Publikováno v:
Pathology & Oncology Research. 3:59-61
The authors present a patient with erythema gyratum repens who had a bronchogenic carcinoma. Autoantibodies and complement at the basement membrane zone of the skin was found which suggest that erythema gyratum repens may have an immunological pathog